Skip to main content
Premium Trial:

Request an Annual Quote

Preparing for US Market, MDx Health Files for CLIA Certification

NEW YORK (GenomeWeb News) – MDx Health today announced the signing of a lease agreement for a laboratory and office facilities in Irvine, Calif.

As a result, it has filed for CLIA certification for the 13,448-square-feet US site. It also has filed for CLIA certification for its facility in Liege, Belgium.

The company said it expects to launch its first assay for prostate cancer next year. In conjunction with a ramp-up of its commercialization operations, MDx Health also announced it has hired Miriam Reyes as senior director of laboratory operations and Beth Davis as senior director of managed care.

"Establishing a US infrastructure that includes CLIA certification will allow us to penetrate the US market more efficiently and is key to our long-term business strategy," Jan Groen, CEO of MDx Health, said in a statement.

In April, the company raised about $11.7 million, part of which was targeted to set up a CLIA laboratory and create a sales and marketing team in the US.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more